Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases

Overview

Journal Clin Diagn Lab Immunol

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2001 Aug 31

PMID 11527792

Citations 23

Authors

V G Hemming

Affiliations

Soon will be listed here.

Citing Articles

Simultaneous Isolation and Purification of Transferrin and Immunoglobulin G from Human Serum-A New Biotech Solution.

cetic D, Miljus G, Dobrijevic Z, Gligorijevic N, Vilotic A, Nedic O Molecules. 2025; 30(5).

PMID: 40076217 PMC: 11901732. DOI: 10.3390/molecules30050993.

Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study.

Choi Y, Kim J, Jang J, Go T, Kim K, Bae K Acute Crit Care. 2023; 38(1):21-30.

PMID: 36935531 PMC: 10030247. DOI: 10.4266/acc.2022.01515.

Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.

Xin H, Rosario-Colon J, Eberle K mSphere. 2023; 8(1):e0058422.

PMID: 36688668 PMC: 9942587. DOI: 10.1128/msphere.00584-22.

Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.

Saied A, Nascimento M, do Nascimento Rangel A, Skowron K, Grudlewska-Buda K, Dhama K J Med Virol. 2022; 94(10):4599-4610.

PMID: 35655326 PMC: 9347534. DOI: 10.1002/jmv.27907.

In vitro and in vivo methods to study bacterial colonization of hydrogel dermal fillers.

Wang Y, Borthwell R, Hori K, Clarkson S, Blumstein G, Park H J Biomed Mater Res B Appl Biomater. 2022; 110(8):1932-1941.

PMID: 35352867 PMC: 10371418. DOI: 10.1002/jbm.b.35050.

References

Rodriguez W, Gruber W, Welliver R, Groothuis J, Simoes E, Meissner H . Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997; 99(3):454-61. DOI: 10.1542/peds.99.3.454. View

King S, Superina R, Andrews W, Winston D, Dunn S, Busuttil R . Randomized comparison of ganciclovir plus intravenous immune globulin (IVIG) with IVIG alone for prevention of primary cytomegalovirus disease in children receiving liver transplants. Clin Infect Dis. 1997; 25(5):1173-9. DOI: 10.1086/516095. View

Ordman C, Jennings C, Janeway C . CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XII. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PREVENTION AND ATTENUATION OF MEASLES. J Clin Invest. 1944; 23(4):541-9. PMC: 435368. DOI: 10.1172/JCI101519. View

NAGINGTON J, GANDY G, Walker J, Gray J . Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit. Lancet. 1983; 2(8347):443-6. DOI: 10.1016/s0140-6736(83)90402-6. View

Hemming V, Fischer G, Prince G . Giant cell pneumonia due to respiratory syncytial virus. Arch Pathol Lab Med. 1985; 109(3):213. View

. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. Pediatrics. 1998; 102(3):531-7. View

Snydman D, Werner B, Tilney N, Kirkman R, Milford E, Cho S . Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. Transplant Proc. 1991; 23(1 Pt 2):1357-60. View

Hemming V, Hall R, Rhodes P, Shigeoka A, Hill H . Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J Clin Invest. 1976; 58(6):1379-87. PMC: 333309. DOI: 10.1172/JCI108593. View

Amer J, Ott E, IBBOTT F, OBrien D, KEMPE C . The effect of monthly gamma-globulin administration on morbidity and mortality from infection in premature infants during the first year of life. Pediatrics. 1963; 32:4-9. View

10.

Hemming V, Prince G, Horswood R, London W, Murphy B, Walsh E . Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis. 1985; 152(5):1083-7. DOI: 10.1093/infdis/152.5.1083. View

11.

Weisman L, Stoll B, Kueser T, Rubio T, Frank C, Heiman H . Intravenous immune globulin therapy for early-onset sepsis in premature neonates. J Pediatr. 1992; 121(3):434-43. DOI: 10.1016/s0022-3476(05)81802-5. View

12.

Sorrentino M, Powers T . Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group. Pediatr Infect Dis J. 2000; 19(11):1068-71. DOI: 10.1097/00006454-200011000-00007. View

13.

Hemming V, Rodriguez W, Kim H, BRANDT C, PARROTT R, BURCH B . Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother. 1987; 31(12):1882-6. PMC: 175820. DOI: 10.1128/AAC.31.12.1882. View

14.

Baba T, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S . Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med. 2000; 6(2):200-6. DOI: 10.1038/72309. View

15.

Snydman D, Werner B, Berardi V, Tilney N, Kirkman R, Milford E . Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med. 1987; 317(17):1049-54. DOI: 10.1056/NEJM198710223171703. View

16.

Nabel G, Sullivan N . Antibodies and resistance to natural HIV infection. N Engl J Med. 2000; 343(17):1263-5. DOI: 10.1056/NEJM200010263431711. View

17.

Stiehm E, Lambert J, Mofenson L, Bethel J, Whitehouse J, Nugent R . Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185. J Infect Dis. 1999; 179(3):567-75. DOI: 10.1086/314637. View

18.

Stiehm E . Human intravenous immunoglobulin in primary and secondary antibody deficiencies. Pediatr Infect Dis J. 1997; 16(7):696-707. DOI: 10.1097/00006454-199707000-00012. View

19.

Weisman L, Anthony B, Hemming V, Fischer G . Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. J Pediatr. 1993; 122(6):929-37. DOI: 10.1016/s0022-3476(09)90023-3. View

20.

Sandberg K, Fasth A, Berger A, Eibl M, Isacson K, Lischka A . Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr. 2000; 137(5):623-8. DOI: 10.1067/mpd.2000.109791. View